149 related articles for article (PubMed ID: 22700161)
1. Nortriptyline for treating enuresis in ADHD--a randomized double-blind controlled clinical trial.
Ghanizadeh A; Haghighat R
Pediatr Nephrol; 2012 Nov; 27(11):2091-2097. PubMed ID: 22700161
[TBL] [Abstract][Full Text] [Related]
2. Randomized clinical study of a histamine H3 receptor antagonist for the treatment of adults with attention-deficit hyperactivity disorder.
Weisler RH; Pandina GJ; Daly EJ; Cooper K; Gassmann-Mayer C;
CNS Drugs; 2012 May; 26(5):421-34. PubMed ID: 22519922
[TBL] [Abstract][Full Text] [Related]
3. Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder.
Newcorn JH; Nagy P; Childress AC; Frick G; Yan B; Pliszka S
CNS Drugs; 2017 Nov; 31(11):999-1014. PubMed ID: 28980198
[TBL] [Abstract][Full Text] [Related]
4. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
[TBL] [Abstract][Full Text] [Related]
5. Buspirone versus methylphenidate in the treatment of children with attention- deficit/ hyperactivity disorder: randomized double-blind study.
Mohammadi MR; Hafezi P; Galeiha A; Hajiaghaee R; Akhondzadeh S
Acta Med Iran; 2012; 50(11):723-8. PubMed ID: 23292622
[TBL] [Abstract][Full Text] [Related]
6. Methylphenidate-Induced Enuresis: 3 Case Reports.
Uzun N; Akinci MA; Karatoprak S
Clin Neuropharmacol; 2021 Jan-Feb 01; 44(1):37-38. PubMed ID: 33252370
[TBL] [Abstract][Full Text] [Related]
7. Attention-deficit/hyperactivity disorder and enuresis: a study about effectiveness of treatment with methylphenidate or desmopressin in a pediatric population.
Ferrara P; Sannicandro V; Ianniello F; Quattrocchi E; Sbordone A; Petitti T; Mariotti P
Minerva Pediatr; 2019 Apr; 71(2):135-138. PubMed ID: 28260347
[TBL] [Abstract][Full Text] [Related]
8. Methylphenidate and atomoxetine for treatment of nocturnal enuresis in a child with attention-deficit hyperactivity disorder.
Bahali K; Ipek H; Uneri OS
Eur Child Adolesc Psychiatry; 2013 Oct; 22(10):649-50. PubMed ID: 23553575
[No Abstract] [Full Text] [Related]
9. Comparative efficacy and acceptability of atomoxetine, lisdexamfetamine, bupropion and methylphenidate in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis with focus on bupropion.
Stuhec M; Munda B; Svab V; Locatelli I
J Affect Disord; 2015 Jun; 178():149-59. PubMed ID: 25813457
[TBL] [Abstract][Full Text] [Related]
10. Reboxetine versus methylphenidate in treatment of children and adolescents with attention deficit-hyperactivity disorder.
Arabgol F; Panaghi L; Hebrani P
Eur Child Adolesc Psychiatry; 2009 Jan; 18(1):53-9. PubMed ID: 18563471
[TBL] [Abstract][Full Text] [Related]
11. Treating enuresis in a patient with ADHD: application of a novel behavioural modification therapy.
Tajima-Pozo K; Ruiz-Manrique G; Montañes F
BMJ Case Rep; 2014 Jun; 2014():. PubMed ID: 24916977
[TBL] [Abstract][Full Text] [Related]
12. Effects of atomoxetine and methylphenidate on sleep in children with ADHD.
Sangal RB; Owens J; Allen AJ; Sutton V; Schuh K; Kelsey D
Sleep; 2006 Dec; 29(12):1573-85. PubMed ID: 17252888
[TBL] [Abstract][Full Text] [Related]
13. Atomoxetine versus methylphenidate in paediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trial.
Wang Y; Zheng Y; Du Y; Song DH; Shin YJ; Cho SC; Kim BN; Ahn DH; Marquez-Caraveo ME; Gao H; Williams DW; Levine LR
Aust N Z J Psychiatry; 2007 Mar; 41(3):222-30. PubMed ID: 17464703
[TBL] [Abstract][Full Text] [Related]
14. A randomized, double-blind, placebo-controlled, parallel-group study of methylphenidate transdermal system in pediatric patients with attention-deficit/hyperactivity disorder.
Findling RL; Bukstein OG; Melmed RD; López FA; Sallee FR; Arnold LE; Pratt RD
J Clin Psychiatry; 2008 Jan; 69(1):149-59. PubMed ID: 18312050
[TBL] [Abstract][Full Text] [Related]
15. Dose-Dependent Enuresis in Methylphenidate Use.
Güleşen O; Bodur Ş; Cöngöloğlu A
Clin Neuropharmacol; 2022 Nov-Dec 01; 45(6):184-186. PubMed ID: 36314572
[TBL] [Abstract][Full Text] [Related]
16. Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
Epstein T; Patsopoulos NA; Weiser M
Cochrane Database Syst Rev; 2014 Sep; (9):CD005041. PubMed ID: 25230710
[TBL] [Abstract][Full Text] [Related]
17. Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial [ISRCTN64132371].
Akhondzadeh S; Mohammadi MR; Khademi M
BMC Psychiatry; 2004 Apr; 4():9. PubMed ID: 15070418
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study.
Adler LA; Zimmerman B; Starr HL; Silber S; Palumbo J; Orman C; Spencer T
J Clin Psychopharmacol; 2009 Jun; 29(3):239-47. PubMed ID: 19440077
[TBL] [Abstract][Full Text] [Related]
19. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.
Research Units on Pediatric Psychopharmacology Autism Network
Arch Gen Psychiatry; 2005 Nov; 62(11):1266-74. PubMed ID: 16275814
[TBL] [Abstract][Full Text] [Related]
20. Atomoxetine ameliorates nocturnal enuresis with subclinical attention-deficit/hyperactivity disorder.
Ohtomo Y
Pediatr Int; 2017 Feb; 59(2):181-184. PubMed ID: 27501068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
